HomePress-release

Redding, California - July 9, 2024

PAP Devices Market to be Worth $6.97 Billion by 2031

Recombinant Coagulation Factors Market Size, Share, Forecast, & Trends Analysis by Type (Factor VIII, Factor IX), Source (CHO, HEK), Application (Hemophilia (Type A, Type B), Others), End User (Hospitals, CRO) - Global Forecast to 2031

Meticulous Research^®—leading global market research company, published a research report titled, ‘PAP Devices Market Size, Share, Forecast, & Trends Analysis by Type [CPAP, BiPAP, APAP, Accessories (Masks, Headgear)], Disease [Obstructive Sleep Apnea, COPD, Respiratory Failure] End User [Hospitals, Home Healthcare Settings] - Global Forecast to 2031.’

According to this latest publication from Meticulous Research^®, the PAP devices market is projected to reach $6.97 billion by 2031, at a CAGR of 5.2% during the forecast period 2024–2031. The growth of this market is driven by the increasing prevalence of respiratory and sleeping disorders, the rising geriatric population suffering from respiratory disorders, the introduction of new sleep apnea devices, growing awareness about the adverse impacts of untreated sleep apnea, and favorable reimbursement policies for sleep apnea therapies and devices. However, PAP devices are expensive and not suitable for patients with certain conditions, which restrains the market’s growth.

Furthermore, technological advancements in positive airway pressure (PAP) devices and a rising preference for out-of-hospital healthcare are expected to offer significant market growth opportunities. However, the side effects of PAP devices and the low adherence rate for sleep apnea devices are challenging the market’s growth.

Key Players

The key players operating in the PAP devices market are ResMed Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Inspire Medical Systems, Inc. (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Rotech Healthcare Inc. (U.S.), Cardinal Health, Inc. (U.S.), Invacare Corporation (U.S.), Cleveland Medical Devices Inc. (U.S.), BMC Medical Co., Ltd. (China), Löwenstein Medical Technology GmbH + Co. KG. (Germany), SomnoMed, Inc. (Australia), Drive DeVilbiss Healthcare Ltd. (U.S.), and SunMed, LLC (U.S.).

PAP Devices Market: Future Outlook

The PAP devices market is segmented based on Product (Continuous Positive Airway Pressure (CPAP) Devices, Bilevel Positive Airway Pressure (BiPAP) Devices, Automatic Positive Airway Pressure (APAP) Devices, Accessories [Masks {Full Face Masks, Nasal Masks, Nasal Pillows/Cushion Masks}], Headgear, Other Accessories), Application (Obstructive Sleep Apnea (OSA), Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Heart Failure), End User (Hospitals and Sleep Clinics, Home Healthcare Settings), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.

Based on product, in 2024, the continuous positive airway pressure (CPAP) devices segment is expected to account for the largest share of 68.2% of the PAP devices market. The large market share of this segment is attributed to the improved reimbursement scenario for CPAP devices, the availability of patient-friendly CPAP devices, and the proven efficacy of CPAP devices in many patients with sleep disorders and other conditions.

Based on disease, in 2024, the obstructive sleep apnea (OSA) segment is expected to account for the largest share of the PAP devices market. The large market share of this segment is attributed to the increasing prevalence of obstructive sleep apnea and the consequent rise in the adoption of PAP devices for sleep disorders. According to the National Institutes of Health (NIH), in 2020, 936 million adults aged 30–69 suffered from mild to severe obstructive sleep apnea (OSA), and 425 million adults aged 30–69 suffered from moderate to severe obstructive sleep apnea globally.

Based on end user, in 2024, the hospitals and sleep clinics segment is expected to account for the largest share of 60.9% of the PAP devices market. This segment's large market share can be attributed to the increasing number of sleep clinics in developed countries, hospitals' financial capability to purchase expensive instruments, and the availability of trained professionals.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, the U.K., Italy, Spain, Switzerland, Netherlands, Sweden, Belgium, Denmark, and the Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), and the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa). In 2024, North America is expected to account for the largest share of 41.5% of the PAP devices market, followed by Europe and Asia-Pacific. Furthermore, in 2024, the U.S. is expected to account for the largest share of the PAP devices market in North America. The market growth in the U.S. is attributed to the growing prevalence of respiratory diseases and sleep disorders, highly developed healthcare infrastructure, the presence of key PAP devices manufacturing companies such as ResMed Inc. (U.S.) and Koninklijke Philips N.V. (Netherlands), and the increasing public and clinical awareness about the adverse impacts of untreated sleep apnea.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5534

Key Questions Answered in the Report:

Which are the high-growth market segments in terms of product, disease, end user, and region/country?
What was the historical market size for PAP devices across the globe?
What are the market forecasts and estimates for the period 2024–2031?
What are the major drivers, restraints, and opportunities in the global PAP devices market?
Who are the major players in the global PAP devices market?
What is the competitive landscape like?
What are the recent developments in the PAP devices market?
What are the different strategies adopted by the major players in the PAP devices market?
What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & Wastewater Technologies

Miscellaneous / Others

Redding, California - July 9, 2024

PAP Devices Market to be Worth $6.97 Billion by 2031

Recombinant Coagulation Factors Market Size, Share, Forecast, & Trends Analysis by Type (Factor VIII, Factor IX), Source (CHO, HEK), Application (Hemophilia (Type A, Type B), Others), End User (Hospitals, CRO) - Global Forecast to 2031

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies